VICTORIA ENGLER: Open Payments
NPI 1376912303 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,351 in 123 payments from 17 companies in 2025. Trend: 2023 $1,789 · 2024 $2,062 · 2025 $2,351
Food & beverage: $2,351
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $473 |
| ABBVIE INC. | 33 | $452 |
| AstraZeneca Pharmaceuticals LP | 7 | $231 |
| GlaxoSmithKline, LLC. | 16 | $231 |
| Exact Sciences Corporation | 5 | $181 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $152 |
| Lilly USA, LLC | 8 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| Abbott Laboratories | 5 | $97 |
| Amgen Inc. | 4 | $73 |
Products named: VRAYLAR, Wegovy, AIRSUPRA, Ozempic, JARDIANCE, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across NY — which companies pay providers there.
